FITE is a hub for streaming live and on-demand combat sports, concerts and exclusive PPV events. Try it out with this 7-day free trial now.

Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs ...

If you're a sports-loving cord-cutter and are curious about what you're missing out on by not having a FITE subscription, here's everything you need to know.

Pnina Fishman, CSO & Chairperson of Can-Fite BioPharma, commented: “We are pleased to offer this compassionate use program with Namodenoson for eligible patient in the US to address the unmet ...

FITE holds a balanced mix of defense and cybersecurity stocks with decent returns, but lacks an edge over peers like PPA and CIBR. Learn why FITE ETF is a hold.

Can-Fite’s cancer and liver drug, Namodenoson, is being evaluated in a Phase IIb trial for the treatment of steatotic liver disease (SLD), a Phase III pivotal trial for hepatocellular carcinoma ...

Can-Fite's liver drug, Namodenoson, is being evaluated in a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH), and enrollment is expected to commence in a Phase III trial ...

Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 ...

Some content on FITE TV is free, but a majority of the quality content is only available if you have a FITE+ subscription. This costs $8 per month or $70 per year.

FITE and AEW Announce Faster Access to AEW Programming — Live AEW Access for fans in Brazil, Italy, Lichtenstein, Luxembourg; Quicker Turnaround for Germany and Switzerland — January 24, 2023 ...

Fortunately, you can stream FITE TV on any device from your iPhone to your Smart TV. All you have to do is download the FITE app, set up your account or buy the fight you’d like to watch and ...

Pnina Fishman, CSO & Chairperson of Can-Fite BioPharma, commented: “We are pleased to offer this compassionate use program with Namodenoson for eligible patient in the US to address the unmet ...